Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Thyroid Cancer · Surgery · Recurrence

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cancer Hospital, Chinese Academy of Medical Science, Beijing, Beijing Municipality, China
Contact: Study coordinator (jie liu, MD) · 8610-87787180

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Biliary Tract Cancer · Breast Cancer · Cervical Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Denver, United States · Miami, United States

Pembrolizumab in High-risk Thyroid Cancer

Differentiated Thyroid Cancer

Abroad (travel likely)RecruitingPHASE2

Pavia, Italy

Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)

Thyroid Cancer · Cancer of the Thyroid

Abroad (travel likely)RecruitingPHASE2

St Louis, United States

Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)

Salivary Gland Cancer · Thyroid Cancer

Abroad (travel likely)RecruitingPHASE2

Singapore, Singapore